Moreover, the p-T181-tau levels were significantly higher in BDE proteins isolated from the plasma of patients with late-stage AD than patients with AD who had only been diagnosed with mild cognitive impairment [34]. The gene discussed is MAPT; the disease is Alzheimer disease.